Because UCSF is home to the Helen Diller Family Comprehensive Cancer Center (HDFCCC), designated and supported by the National Cancer Institute (NCI), all protocols designed to conduct research on subjects diagnosed with, or at risk for, cancer are subject to additional review and monitoring processes not required of non-cancer protocols. Therefore, in addition to requiring review by the Committee on Human Research (CHR), your cancer-related protocols are subject to:
Such protocols may also be eligible to receive centralized support from the Investigational Trials Resource.
Other Clinical Research Resources
* Can include studies written by an investigator at another institution.
This unit is supported by a National Cancer Institute Cancer Center Support Grant (5P30CA082103). Any publications related to work done by this core should reference grant number 5P30CA082103 and must include a PMCID as required by the NIH. For complete instructions on how to acknowledge funding sources, please see http://grants.nih.gov/grants/acknow.htm. For more information on how to obtain a PMCID, please see http://publicaccess.nih.gov/submit_process.htm.
For more information on the CCSG, please contact Erin Bank, PhD, at email@example.com.